Copyright Notice
The contents of this document may be used and reprinted without permission. Endorsements by NESR, NGAD, CNPP, FNS, or USDA of derivative products developed from this work may not be stated or implied.
< PrevNext >
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
< PrevNext >
Omega-3 fatty acids from Supplements Consumed before and during Pregnancy and Lactation and Developmental Milestones, Including Neurocognitive Development, in the Child: A Systematic Review
Sharon Donovan, PhD, RD, Kathryn Dewey, PhD, Rachel Novotny, PhD, RDN, LD, Jamie Stang, PhD, MPH, RD, Elsie Taveras, MD, MPH, Ronald Kleinman, MD, Julie Nevins, PhD, Ramkripa Raghavan, DrPH, MPH, MSc, Sara Scinto-Madonich, MS, Sudha Venkatramanan, PhD, MSc, Gisela Butera, MLIS, MEd, Nancy Terry, MS, MLS, and Julie Obbagy, PhD, RD.
Author Information and AffiliationsAlexandria (VA): USDA Nutrition Evidence Systematic Review; 2020 Jul.
TECHNICAL ABSTRACT
Background
- This important public health question was identified by the U.S. Departments of Agriculture (USDA) and Health and Human Services (HHS) to be examined by the 2020 Dietary Guidelines Advisory Committee.
- The 2020 Dietary Guidelines Advisory Committee, Pregnancy and Lactation Subcommittee conducted a systematic review to answer this question with support from the Nutrition Evidence Systematic Review (NESR) team.
- The goal of this systematic review was to examine the following question: What is the relationship between omega-3 fatty acid supplements consumed before and during pregnancy and lactation and developmental milestones, including neurocognitive development, in the child?
Conclusion statements and grades
- Pregnancy
- Limited evidence suggests that omega-3 fatty acid supplementation during pregnancy may result in favorable cognitive development in the child. (Grade: Limited)
- Insufficient evidence is available to determine the relationship between omega-3 fatty acid supplementation during both pregnancy and lactation, or during pregnancy only, and language and social emotional development in the child. (Grade: Grade not assignable)
- Insufficient evidence is available to determine the relationship between omega-3 fatty acid supplementation during pregnancy and motor and visual development, academic performance, and the risk of attention-deficit disorder, attention-deficit/hyperactivity disorder, and autism spectrum disorder in the child. (Grade: Grade not assignable)
- No evidence is available to determine the relationship between omega-3 fatty acid supplementation during both pregnancy and lactation, or during pregnancy only, and anxiety or depression in the child. (Grade: Grade not assignable)
- Insufficient evidence is available to determine the relationship between omega-3 fatty acid supplementation during both pregnancy and lactation and cognitive development in the child. (Grade: Grade not assignable)
- No evidence is available to determine the relationship between omega-3 fatty acid supplementation during both pregnancy and lactation and visual development, academic performance, or the risk of attention-deficit disorder, attention-deficit/hyperactivity disorder, or autism spectrum disorder in the child. (Grade: Grade not assignable)
- Lactation
- Insufficient evidence is available to determine the relationship between omega-3 fatty acid supplementation consumed during both pregnancy and lactation or during lactation alone, and cognitive, language, motor, and visual development in the child. (Grade: Grade not assignable)
- No evidence is available to determine the relationship between omega-3 fatty acid supplementation consumed during both pregnancy and lactation or during lactation alone and academic performance, anxiety, depression, or the risk of attention-deficit disorder, attention-deficit/hyperactivity disorder, or autism spectrum disorder in the child. (Grade: Grade not assignable)
- No evidence is available to determine the relationship between omega-3 fatty acid supplementation consumed during lactation and social-emotional development in the child. (Grade: Grade not assignable)
Methods
- Literature search was conducted using 4 databases (PubMed, Cochrane, Embase, and CINAHL) to identify articles that evaluated an intervention or exposure of omega-3 fatty acid supplements consumed before and during pregnancy and/or lactation and the outcome of developmental milestones, including neurocognitive development, in the child. A manual search was also conducted to identify articles that may not have been included in the electronic databases searched. Articles were screened by two NESR analysts independently for inclusion based on pre-determined criteria.
- Data extraction and risk of bias assessment were conducted for each included study, and both were checked for accuracy. The Committee qualitatively synthesized the body of evidence to inform development of a conclusion statement(s), and graded the strength of evidence using pre-established criteria for risk of bias, consistency, directness, precision, and generalizability.
Summary of the evidence
- Pregnancy only, and both pregnancy and lactation
- This systematic review included 31 articles from 14 randomized controlled trials (RCTs) and 1 prospective cohort study (PCS) published between 1980 and 2020.
- Studies included in this review assessed interventions/exposures during:
- Pregnancy only: 11 RCTs (24 articles); 1 PCS (1 article)
- Both pregnancy and lactation: 3 RCTs (6 articles)
- 11 of the 14 RCTs assessed cognitive development
- Eight RCTs delivered omega-3 fatty acid supplements during pregnancy alone. Of those 8 RCTs, 5 studies (11 articles) reported at least one statistically significant finding that supplementation resulted in favorable cognitive development in the child. One study reported at least one statistically significant finding that supplementation resulted in unfavorable measures of cognitive development in the child. All 8 studies reported at least one statistically non-significant result. Overall, results were inconsistent across different measures both within and between studies.
- Three RCTs delivered omega-3 fatty acid supplements during both pregnancy and lactation. Of those 3 RCTs, 1 study reported at least one statistically significant finding that supplementation resulted in favorable cognitive development in the child. All 3 studies reported at least one statistically non-significant result.
- For language, motor, visual, and social-emotional development, findings were inconsistent and therefore a conclusion statement could not be drawn. Although all studies reported at least one statistically non-significant result, the number and direction of statistically significant findings varied across the body of evidence.
- Only 1 study examined academic performance; therefore, a conclusion could not be drawn.
- No evidence was available on omega-3 fatty acid supplementation and anxiety or depression.
- Only 1 study (2 articles) assessed the risk of attention-deficit disorder (ADD) or attention-deficit/hyperactivity disorder (ADHD); therefore a conclusion could not be drawn.
- Only 1 RCT and 1 PCS study assessed risk of autism spectrum disorder (ASD), and both had methodological limitations; therefore, the evidence was deemed insufficient to draw a conclusion.
- The ability to draw strong conclusions was limited by the following issues:
- Wide variation in the developmental domains assessed, as well as in the measures used to evaluate child performance in each of those domains, which limited the ability to compare results across studies.
- Potential risk of bias due to missing outcome data. Further, a lack of pre-registered data analysis plans potentially increased the risk of bias due to selectivity in results presented.
- Findings were mixed both within and between studies, and these inconsistencies could not be explained by methodological differences.
- Although some studies published results from multiple follow-up assessments, an insufficient number of studies were available to investigate the relationship between omega-3 fatty acid supplementation and developmental milestones in the child for many exposure-outcome pairs. Additionally, several studies did not provide evidence of sufficient sample size to detect effects, either because the study did not achieve the required sample size estimated by power calculations or because the study did not report a power calculation. This is particularly true for the long-term outcome assessments.
- People with lower socioeconomic status, adolescents, and racially and ethnically diverse populations were underrepresented in the body of evidence.
- Lactation only, and both pregnancy and lactation
- This systematic review included 8 articles from 4 RCTs published between 1980 and 2020.
- Studies included in this review assessed interventions/exposures during:
- Both pregnancy and lactation: 3 RCTs (6 articles)
- Lactation alone: 1 RCT (2 articles)
- All 4 RCTs assessed cognitive development
- Three RCTs provided omega-3 fatty acid supplements during both pregnancy and lactation. Of those 3 RCTs, 1 study reported at least one statistically significant finding that supplementation resulted in favorable cognitive development in the child. All 3 studies reported at least one statistically non-significant result.
- One RCT provided omega-3 fatty acid supplements during lactation alone and showed a benefit of supplementation on one measure of cognitive development in the child. The study also reported statistically non-significant results on other measures of cognitive development.
- For language, motor, and social-emotional development, findings were inconsistent and therefore a conclusion statement could not be drawn. Although all studies reported at least one statistically non-significant result, the number and direction of statistically significant findings varied across the body of evidence.
- No evidence was available on omega-3 fatty acid supplementation and visual development, academic performance, anxiety, depression or the risk of ADD, ADHD, or ASD.
- The ability to draw strong conclusions was limited by the following issues:
- Wide variation in the developmental domains assessed, as well as in the measures used to evaluate child performance in each of those domains, limited the ability to compare results across studies.
- Missing outcome data raised concerns about risk of bias. Further, a lack of preregistered data analysis plans potentially increased the risk of bias due to selectivity in results presented.
- Findings were mixed both within and between studies, and these inconsistencies could not be explained by methodological differences.
- Although some studies published results from multiple follow-up assessments, an insufficient number of studies were available to investigate the relationship between omega-3 fatty acid supplementation and developmental milestones in the child for many exposure-outcome pairs. Additionally, multiple studies did not provide evidence of sufficient sample size to detect effects, either because the study did not achieve the required sample size estimated by power calculations or because the study did not report a power calculation. This is particularly true for the long-term outcome assessments.
- People with lower socioeconomic status, adolescents, and racially and ethnically diverse populations were underrepresented in the body of evidence.
Contents
FUNDING SOURCE: United States Department of Agriculture, Food and Nutrition Service, Center for Nutrition Policy and Promotion, Alexandria, VA
Suggested citation:
Donovan S, Dewey K, Novotny R, Stang J, Taveras E, Kleinman R, Nevins J, Raghavan R, Scinto-Madonich S, Venkatramanan S, Butera G, Terry N, Obbagy J. Omega-3 fatty acids from Supplements Consumed before and during Pregnancy and Lactation and Developmental Milestones, Including Neurocognitive Development, in the Child: A Systematic Review. July 2020. U.S. Department of Agriculture, Food and Nutrition Service, Center for Nutrition Policy and Promotion, Nutrition Evidence Systematic Review. Available at: https://doi.org/10.52570/NESR.DGAC2020.SR0206
In accordance with Federal civil rights law and U.S. Department of Agriculture (USDA) civil rights regulations and policies, the USDA, its Agencies, offices, and employees, and institutions participating in or administering USDA programs are prohibited from discriminating based on race, color, national origin, religion, sex, gender identity (including gender expression), sexual orientation, disability, age, marital status, family/parental status, income derived from a public assistance program, political beliefs, or reprisal or retaliation for prior civil rights activity, in any program or activity conducted or funded by USDA (not all bases apply to all programs). Remedies and complaint filing deadlines vary by program or incident.
Persons using assistive technology should be able to access information in this report. For further assistance please email vog.ADSU@RSEN.NF.MS.
Persons with disabilities who require alternative means of communication for program information (e.g., Braille, large print, audiotape, American Sign Language, etc.) should contact the responsible Agency or USDA’s TARGET Center at (202) 720-2600 (voice and TTY) or contact USDA through the Federal Relay Service at (800) 877-8339. Additionally, program information may be made available in languages other than English.
To file a program discrimination complaint, complete the USDA Program Discrimination Complaint Form, AD-3027, found online at How to File a Program Discrimination Complaint and at any USDA office or write a letter addressed to USDA and provide in the letter all of the information requested in the form. To request a copy of the complaint form, call (866) 632-9992. Submit your completed form or letter to USDA by:
- (1)
mail: U.S. Department of Agriculture, Office of the Assistant Secretary for Civil Rights, 1400 Independence Avenue, SW, Washington, D.C. 20250-9410;
- (2)
fax: (202) 690-7442; or
- (3)
email: vog.adsu@ekatni.margorp.
USDA is an equal opportunity provider, employer, and lender.
Related citation: Dietary Guidelines Advisory Committee. Scientific Report of the 2020 Dietary Guidelines Advisory Committee: Advisory Report to the Secretary of Agriculture and the Secretary of Health and Human Services. July 2020. U.S. Department of Agriculture, Agricultural Research Service. Available at: https://doi.org/10.52570/DGAC2020
- NLM CatalogRelated NLM Catalog Entries
- Review Seafood Consumption during Pregnancy and Lactation and Neurocognitive Development in the Child: A Systematic Review[ 2020]Review Seafood Consumption during Pregnancy and Lactation and Neurocognitive Development in the Child: A Systematic ReviewSnetselaar L, Bailey R, Sabaté J, Van Horn L, Schneeman B, Spahn J, Kim JH, Bahnfleth C, Butera G, Terry N, et al. 2020 Jul
- Review Maternal Diet during Pregnancy and Lactation and Risk of Child Food Allergies and Atopic Allergic Diseases: A Systematic Review[ 2020]Review Maternal Diet during Pregnancy and Lactation and Risk of Child Food Allergies and Atopic Allergic Diseases: A Systematic ReviewDonovan S, Dewey K, Novotny R, Stang J, Taveras E, Kleinman R, Raghavan R, Nevins J, Scinto-Madonich S, Butera G, et al. 2020 Jul
- Review Seafood Consumption during Childhood and Adolescence and Neurocognitive Development: A Systematic Review[ 2020]Review Seafood Consumption during Childhood and Adolescence and Neurocognitive Development: A Systematic ReviewSnetselaar L, Bailey R, Sabaté J, Van Horn L, Schneeman B, Spahn J, Kim JH, Bahnfleth C, Butera G, Terry N, et al. 2020 Jul
- Review Beverage Consumption During Pregnancy and Birth Weight: A Systematic Review[ 2020]Review Beverage Consumption During Pregnancy and Birth Weight: A Systematic ReviewMayer-Davis E, Leidy H, Mattes R, Naimi T, Novotny R, Schneeman B, Kingshipp BJ, Spill M, Cole NC, Bahnfleth CL, et al. 2020 Jul
- Review Beverage Consumption and Growth, Size, Body Composition, and Risk of Overweight and Obesity: A Systematic Review[ 2020]Review Beverage Consumption and Growth, Size, Body Composition, and Risk of Overweight and Obesity: A Systematic ReviewMayer-Davis E, Leidy H, Mattes R, Naimi T, Novotny R, Schneeman B, Kingshipp BJ, Spill M, Cole NC, Bahnfleth CL, et al. 2020 Jul
- Omega-3 fatty acids from Supplements Consumed before and during Pregnancy and La...Omega-3 fatty acids from Supplements Consumed before and during Pregnancy and Lactation and Developmental Milestones, Including Neurocognitive Development, in the Child: A Systematic Review
Your browsing activity is empty.
Activity recording is turned off.
See more...